BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31689672)

  • 21. Future Challenges of Multimodality Imaging.
    López-Mora DA; Lagos LA; Estorch M; Carrio I
    Recent Results Cancer Res; 2020; 216():905-918. PubMed ID: 32594412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming Nuclear Medicine with Nanoradiopharmaceuticals.
    Roy I; Krishnan S; Kabashin AV; Zavestovskaya IN; Prasad PN
    ACS Nano; 2022 Apr; 16(4):5036-5061. PubMed ID: 35294165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in nuclear medicine: current concepts.
    Noto RB; Scheiner JD
    Med Health R I; 1999 Jun; 82(6):190-4. PubMed ID: 10402834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.
    Chakravarty R; Goel S; Dash A; Cai W
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):181-204. PubMed ID: 28124549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.
    Goel S; England CG; Chen F; Cai W
    Adv Drug Deliv Rev; 2017 Apr; 113():157-176. PubMed ID: 27521055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging.
    Bischof Delaloye A; Carrió I; Cuocolo A; Knapp W; Gourtsoyiannis N; McCall I; Reiser M; Silberman B
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1147-51. PubMed ID: 17607577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabeled nanoparticles for multimodality tumor imaging.
    Xing Y; Zhao J; Conti PS; Chen K
    Theranostics; 2014; 4(3):290-306. PubMed ID: 24505237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EANM-ESR white paper on multimodality imaging.
    Stegger L; Schäfers M; Weckesser M; Schober O
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):677-80. PubMed ID: 18273612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Situation of supply and boom of PET imaging: what is the future for technetium-99m in nuclear medicine?].
    Maia S; Ayachi Hatit N; Paycha F
    Ann Pharm Fr; 2011 May; 69(3):155-64. PubMed ID: 21570540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.
    Munley MT; Marks LB; Scarfone C; Sibley GS; Patz EF; Turkington TG; Jaszczak RJ; Gilland DR; Anscher MS; Coleman RE
    Lung Cancer; 1999 Feb; 23(2):105-14. PubMed ID: 10217614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiolabeling of Theranostic Nanosystems.
    Das S; Imlimthan S; Airaksinen AJ; Sarparanta M
    Adv Exp Med Biol; 2021; 1295():49-76. PubMed ID: 33543455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The growing development of multimodality imaging in oncology.
    Papathanassiou D; Liehn JC
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):60-5. PubMed ID: 18765183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trending: Radioactive and Fluorescent Bimodal/Hybrid Tracers as Multiplexing Solutions for Surgical Guidance.
    van Leeuwen FWB; Schottelius M; Brouwer OR; Vidal-Sicart S; Achilefu S; Klode J; Wester HJ; Buckle T
    J Nucl Med; 2020 Jan; 61(1):13-19. PubMed ID: 31712326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiolabelling of nanomaterials for medical imaging and therapy.
    Pellico J; Gawne PJ; T M de Rosales R
    Chem Soc Rev; 2021 Mar; 50(5):3355-3423. PubMed ID: 33491714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and precision of radioactivity quantification in nuclear medicine images.
    Frey EC; Humm JL; Ljungberg M
    Semin Nucl Med; 2012 May; 42(3):208-18. PubMed ID: 22475429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paediatric nuclear medicine imaging.
    Biassoni L; Easty M
    Br Med Bull; 2017 Sep; 123(1):127-148. PubMed ID: 28910997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.